Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2019 | Cord vs. haplo in SAA

Rainer Storb • 26 Oct 2019
COSTEM 2019
Anemias Aplastic Anemia

Rainer Storb, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, outlines the differences between cord and haploidentical donor sources in SAA and also evaluates the efficacy of haploidentical as a preferred donor source to cord in severe aplastic anemia (SAA). This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

More from Rainer Storb

ASCT in the outpatient setting
1:58
ASCT in the outpatient setting
Rainer Storb • 28 Oct 2019
Total body irradiation vs. chemotherapy-based myeloablative conditioning for ASCT
0:55
Total body irradiation vs. chemotherapy-based myeloablative conditioning for ASCT
Rainer Storb • 26 Oct 2019

Related Videos

Managing ruxolitinib-associated anemia in myelofibrosis: dose reduction and add-on therapies
1:48
Managing ruxolitinib-associated anemia in myelofibrosis: dose reduction and add-on therapies
Ciro Rinaldi • 10 Sep 2026
Beyond JAK inhibitors: emerging approaches to anemia management in myelofibrosis
4:29
Beyond JAK inhibitors: emerging approaches to anemia management in myelofibrosis
Prithviraj Bose • 18 Sep 2026
Distinguishing disease- and treatment-related anemia in myelofibrosis
1:42
Distinguishing disease- and treatment-related anemia in myelofibrosis
Aaron Gerds • 21 Sep 2026
Insights into the evolving treatment paradigm for myelofibrosis beyond spleen and symptom control
1:16
Insights into the evolving treatment paradigm for myelofibrosis beyond spleen and symptom control
Haifa Kathrin Al-Ali • 13 Jun 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals